Gene-edited stem cell transplant shows promise for aggressive blood cancers (IMAGE)

WashU Medicine

Gene-edited stem cell transplant shows promise for aggressive blood cancers

Caption

A new study led by WashU Medicine researchers shows that, for blood cancer patients, a genetically engineered stem cell transplant helps prevent toxic side effects and potentially improves the effectiveness of therapies.

Credit

Sara Moser/WashU Medicine

Usage Restrictions

Credit Sara Moser/WashU Medicine

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.